Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Genetics and Genomic Sciences, Department of Oncological Sciences, Mount Sinai Icahn School of Medicine, New York, NY, USA.
Adv Exp Med Biol. 2022;1361:249-268. doi: 10.1007/978-3-030-91836-1_14.
Precision oncology is an innovative approach to cancer care in which diagnosis, prognosis, and treatment are informed by the individual patient's genetic and molecular profile. The rapid development of novel high-throughput omics technologies in recent years has led to the generation of massive amount of complex patient data, which in turn has prompted the development of novel computational infrastructures, platforms, and tools to store, retrieve, and analyze this data efficiently. Artificial intelligence (AI), and in particular its subfield of machine learning, is ideal for deciphering patterns in large datasets and offers unique opportunities for advancing precision oncology. In this chapter, we provide an overview of the various public data resources and applications of AI in precision oncology and cancer research, from subtype identification to drug prioritization, using multi-omics datasets. We also discuss the impact of AI-powered medical image analysis in oncology and present the first diagnostic FDA-approved AI-powered tools.
精准肿瘤学是一种创新的癌症治疗方法,其诊断、预后和治疗都基于个体患者的遗传和分子特征。近年来新型高通量组学技术的快速发展产生了大量复杂的患者数据,这反过来又促使开发了新型计算基础设施、平台和工具,以有效地存储、检索和分析这些数据。人工智能(AI),特别是其机器学习子领域,非常适合于破译大型数据集的模式,并为推进精准肿瘤学提供了独特的机会。在本章中,我们将概述各种公共数据资源和 AI 在精准肿瘤学和癌症研究中的应用,从亚类识别到药物优先级排序,都使用了多组学数据集。我们还讨论了 AI 赋能的医学图像分析在肿瘤学中的影响,并介绍了第一个获得 FDA 批准的 AI 赋能的诊断工具。